Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
JanOne has successfully completed the formulation of JAN101, its potential treatment for Peripheral Artery Disease expected to soon be in Phase 2b trials.
read more
Thursday, February 06, 2020
JanOne has executed a manufacturing agreement for the formulation and manufacturing of TV1001SR, a treatment for Peripheral Artery Disease.
read more
Wednesday, November 27, 2019
JanOne has announced a licensing agreement for TV1001SR, a treatment for Peripheral Artery Disease.
read more
Jacobs has been selected to provide EPCMCQV to retrofit AstraZeneca’s West Chester, Ohio manufacturing facility to deliver a potential vaccine to fight the COVID-19 virus.
read more
Thursday, December 14, 2017
Izana Bioscience has launched as a new clinical-stage translational medicine company.
read more
IVERIC bio and Catalent Biologics have entered into an agreement for production and manufacturing of GMP-grade AAV vector for IVERIC bio’s gene therapy product candidates, IC-100.
read more
Tuesday, November 23, 2021
iSpecimen Inc., an online marketplace for human biospecimens, today announced that it has been contracted to support new advanced research on COVID-19 seeking insights on its transmissibility, variants, outcomes, and testing validity among multiple ...
read more
At the 3rd annual ISPE-FDA CGMP Conference, ISPE announced the official launch of its Metrics Pilot Program. The launch of the pilot, headed by ISPE’s PQLI® Quality Metrics Team, is a major milestone in the overall project from ISPE. The pilot is now...
read more
Wednesday, April 25, 2012
ISPE announced today the Food and Drug Administration (FDA) will co-sponsor the upcoming “Redefining the ‘C’ in ‘CGMP’” Conference in Baltimore, Md. USA on 4 – 5 June 2012. The conference is the first joint ISPE-FDA conference focused on CGMP issues.
read more
ISPE, the International Society for Pharmaceutical Engineering, announced today that it will work with stakeholders world-wide to produce a Drug Shortages Prevention Plan to guide the pharmaceutical and biopharmaceutical industry in establishing ...
read more
Irvine Pharmaceutical Services, a leading provider of cGMP contract development and manufacturing services for the pharmaceutical, biotech, and medical device industries since 1988, is pleased to announce it successfully completed a five day cGMP ...
read more
IQVIA™, a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, announced the opening of a state-of-the-art, 160,000-square-foot lab facility for its Q2 Solutions subsidiary...
read more
Monday, November 06, 2017
InVitria has announced the launch of a new media formulation service at the international BIO-Europe conference in Berlin, Germany.
read more
Monday, February 22, 2021
Intravacc announced its new modern pilot production plant will soon be operational.
read more
Thursday, January 21, 2021
Intravacc announced a candidate polyvalent inactivated coxsackievirus B vaccine it developed and manufactured for Provention Bio has entered into a first in human Phase I clinical study.
read more